Streetbeat News

Equity Actions

CUTR

Cutera has appointed Taylor Harris as CEO, leading to a rise in the company's shares. Piper Sandler has upgraded the stock to Neutral from Underweight and raised the price target to $18 from $14.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 5:01 pm

INVO

INVO BioScience has announced a 1-for-20 reverse stock split, leading to a rise in its share prices.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 4:58 pm

ABVC

ABVC BioPharma has priced a registered direct offering of 500,000 shares at $3.50/share, raising $1.75 million. This has led to a decrease in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 4:57 pm

ASXC

Asensus Surgical has announced a $10 million registered direct offering, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 27, 2023 | 4:55 pm

ESRT

Josh Brown, a regular CNBC contributor, announced live on the network that he has purchased more shares of Empire State Realty Trust (ESRT).

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 4:52 pm

FDX

Unusual options activity has been observed for FedEx (NYSE:FDX), with a large position indicating a bullish stance. The overall sentiment of these big-money traders is split between 63% bullish and 36% bearish. The price target range for FedEx over the last 3 months has been $150.0 to $280.0. The current price of FDX is up 0.56% at $269.64. The next earnings are expected to be released in 55 days.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 4:48 pm

URGN

UroGen Pharma Ltd's stock is surging after the company released positive topline data from its Phase 3 trials ATLAS and ENVISION studying UGN-102 for bladder cancer. Both trials met their primary endpoints, showing significant disease-free survival and complete response rates. The company also announced a private placement of approximately $120 million. URGN shares are up 42.70% at $12.86.

Portfolio Pulse from Vandana Singh

July 27, 2023 | 4:46 pm

ASXC

CTCX

FEMY

META

MRSN

NOA

TPIC

U.S. stocks traded higher with the Nasdaq Composite gaining around 1%. Meta Platforms, Inc. (NASDAQ:META) shares jumped 7% after reporting better-than-expected Q2 results. Carmell Therapeutics Corporation (NASDAQ:CTCX) shares shot up 41% after announcing a merger with Axolotl Biologix. Femasys Inc. (NASDAQ:FEMY) shares shot up 174% after the US Patent and Trademark Office issued a Notice of Allowance for FemBloc. North American Construction Group Ltd. (NYSE:NOA) shares were up 38% after posting better-than-expected Q2 results. Mersana Therapeutics, Inc. (NASDAQ:MRSN) shares dropped 77% after UPLIFT clinical trial did not meet primary endpoint. TPI Composites, Inc. (NASDAQ:TPIC) shares were down 35% after lowering its 2023 forecast. Asensus Surgical, Inc. (NYSE:ASXC) shares fell 35% after reporting a $10 million registered direct offering.

Portfolio Pulse from Lisa Levin

July 27, 2023 | 4:16 pm

CCL

Investor Business Daily's SwingTrader has reportedly purchased stock in Carnival Corporation (CCL).

Portfolio Pulse from Happy Mohamed

July 27, 2023 | 4:04 pm

CPRT

Copart Inc.'s shares are currently trading at $89.20, marking a 0.42% decrease. Despite a 1.15% decrease over the past month, the stock has risen by 39.31% over the past year. The company's price-to-earnings (P/E) ratio is lower than the industry average, which could indicate that the stock is undervalued or that it might perform worse than its industry peers.

Portfolio Pulse from Benzinga Insights

July 27, 2023 | 4:00 pm